0001209191-18-011686.txt : 20180220 0001209191-18-011686.hdr.sgml : 20180220 20180220203020 ACCESSION NUMBER: 0001209191-18-011686 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180215 FILED AS OF DATE: 20180220 DATE AS OF CHANGE: 20180220 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kroll Werner CENTRAL INDEX KEY: 0001609320 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-10961 FILM NUMBER: 18626741 MAIL ADDRESS: STREET 1: 12544 HIGH BLUFF DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: QUIDEL CORP /DE/ CENTRAL INDEX KEY: 0000353569 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 942573850 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12544 HIGH BLUFF DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 8585521100 MAIL ADDRESS: STREET 1: 12544 HIGH BLUFF DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: MONOCLONAL ANTIBODIES INC /DE/ DATE OF NAME CHANGE: 19910210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-02-15 0 0000353569 QUIDEL CORP /DE/ QDEL 0001609320 Kroll Werner 12544 HIGH BLUFF DRIVE, SUITE 200 SAN DIEGO CA 92130 0 1 0 0 SVP, R&D Common Stock 2018-02-15 4 A 0 7171 0.00 A 13827 D Common Stock 2018-02-15 4 F 0 2479 45.10 D 11348 D Reporting Person acquired these shares in connection with full achievement of performance metrics associated with performance-based restricted stock units awarded on 2/15/2017. The amount of securities beneficially owned prior to this transaction included an additional 664 shares due to the Reporting Person's purchase of shares pursuant to the Issuer's Employee Stock Purchase Plan. Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of performance-based restricted stock units. Robert J. Bujarski, attorney-in-fact for Werner Kroll 2018-02-20